Essays about: "marknader"

Showing result 1 - 5 of 340 essays containing the word marknader.

1. 1. An Attempt at Pricing Zero-Coupon Bonds under the Vasicek Model with a Mean Reverting Stochastic Volatility Factor

   University essay from KTH/Matematik (Avd.)

   Author : Benjamin Neander; Victor Mattson; [2023]
   Keywords : Zero-coupon bond; Vasicek model; Two-factor interest rate model; Stochastic volatility.; Nollkupongobligation; Vasicek model; Räntemodell med två faktorer; Stokastisk volatilitet.;

   Abstract : Empirical evidence indicates that the volatility in asset prices is not constant, but varies over time. However, many simple models for asset pricing rest on an assumption of constancy. READ MORE

3. 2. Capabilities and partnership factors needed to offer product-service systems from a manufacturer-reseller perspective : A Case study of a European truck manufacturer in the Southeast Asian market

   University essay from Luleå tekniska universitet/Institutionen för ekonomi, teknik, konst och samhälle

   Author : John Johansson Malm; Lukas Broman; [2023]
   Keywords : Capabilities; Partnership factors; Product-service system; Servitization; Manufacturer-reseller perspective; Kapabiliteter; partnerskapsfaktorer; PSS; Tjänstefiering; Tillverkare-återförsäljarperspektiv;

   Abstract : Purpose: This study aims to examine what is needed by manufacturers and their resellers in thetruck manufacturing industry that wants to pursue a result-oriented PSS. More specifically, thisstudy aims to answer what capabilities are needed for the actors and address what partnershipfactor is needed for collaboration. READ MORE

4. 3. Reducing corporatescope 1 emissions on a voluntarily basiswith a focus on European biomethane and hydrogen markets

   University essay from KTH/Skolan för industriell teknik och management (ITM)

   Author : Vic van Mol; [2023]
   Keywords : Scope 1 emission reduction; sustainability; biomethane; hydrogen; markets; companies; SBTi; GHG Protocol; Scope 1 utsläppsminskning; hållbarhet; biometan; väte; marknader; företag; SBTi; GHG Protocol;

   Abstract : This research project represents a collaborative effort between E&C Consultants, an international energy procurement consultancy, and aims to address the increasing demand for guidance on scope 1 emissions reduction strategies expressed by their clients. From a procurement perspective, companies are actively seeking alternative commodities, such as biomethane or hydrogen, to substitute their natural gas consumption. READ MORE

5. 4. Culpa in Code: Exploring Autonomous Algorithmic Collusion under EU Competition Law

   University essay from Lunds universitet/Juridiska fakulteten; Lunds universitet/Juridiska institutionen

   Author : Carl Brinnen; [2023]
   Keywords : AI; Algorithms; Competition Law; Anti-trust Law; EU; Fault; Intent; Negligence; Dolus; Culpa; Digital Eye; Law and Political Science;

   Abstract : Algorithms wield an increasingly significant influence in our everyday lives. Both in traditional brick-and-mortar markets, and particularly in the digital markets, companies use algorithms for various operations. Instances of algorithmic collusion have already surfaced. However, a more signifi-cant threat may await. READ MORE

6. 5. Predictability of Shareholder Return in Medical Device Companies : Investment Decisions from thePerspective of an Investment Firm

   University essay from KTH/Skolan för industriell teknik och management (ITM)

   Author : Daniel Gröttheim; [2023]
   Keywords : Medical device companies; pre-market approval; total return; abnormal return; stock return prediction; market anomalies; free cash flow yield; efficient markets; financial crisis; investment firm; Medicintekniska företag; förmarknadsgodkännande; totalavkastning; abnorm avkastning; aktieavkastningsförutsägbarhet; marknadsavvikelser; avkastning på fritt kassaflöde; effektiva marknader; finanskris; investeringsföretag;

   Abstract : The medical device industry has seen rapid growth in recent years, and the increasing valuations has caught the attention of investors. Although their growth has outpaced many indices, medical device companies’ reliance on capital to finance research, patents, and clinical testing to reach pre-market approval makes due-diligence and the investment research process especially complex. READ MORE